 the recommendations for symptomatic patients with carotid stenosis.
1. Management of acute stroke.
a. Presentation within 0-6 hours. The National Institute of Neurological Disorders and Stroke trial established

Ricotta et al e19

the efficacy of intravenous recombinant tissue plasminogen
activator in the treatment of acute stroke, if therapy could
be initiated â±•3 hours of the onset of symptoms.230 Efficacy
has